Digital biomarkers for Alzheimer’s disease: the mobile/wearable devices opportunity

Alzheimer’s Disease (AD) represents a major and rapidly growing burden to the healthcare ecosystem. A growing body of evidence indicates that cognitive, behavioral, sensory, and motor changes may precede clinical manifestations of AD by several years. Existing tests designed to diagnose neurodegener...

Descripción completa

Detalles Bibliográficos
Autores principales: Kourtis, Lampros C., Regele, Oliver B., Wright, Justin M., Jones, Graham B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526279/
https://www.ncbi.nlm.nih.gov/pubmed/31119198
http://dx.doi.org/10.1038/s41746-019-0084-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526279/
https://www.ncbi.nlm.nih.gov/pubmed/31119198
http://dx.doi.org/10.1038/s41746-019-0084-2

Ejemplares similares